Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Long-Term Investments (2022 - 2024)

OptimizeRx (OPRX) has disclosed Long-Term Investments for 3 consecutive years, with $434000.0 as the latest value for Q2 2024.

  • Quarterly Long-Term Investments changed N/A to $434000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $434000.0 through Jun 2024, changed N/A year-over-year, with the annual reading at $568000.0 for FY2023, 98.98% down from the prior year.
  • Long-Term Investments hit $434000.0 in Q2 2024 for OptimizeRx, down from $501000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $55.9 million in Q4 2022 to a low of $434000.0 in Q2 2024.
  • Historically, Long-Term Investments has averaged $11.6 million across 3 years, with a median of $568000.0 in 2023.
  • Biggest YoY gain for Long-Term Investments was 98.98% in 2023; the steepest drop was 98.98% in 2023.
  • Year by year, Long-Term Investments stood at $55.9 million in 2022, then crashed by 98.98% to $568000.0 in 2023, then fell by 23.59% to $434000.0 in 2024.
  • Business Quant data shows Long-Term Investments for OPRX at $434000.0 in Q2 2024, $501000.0 in Q1 2024, and $568000.0 in Q4 2023.